CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong · Delayed Price · Currency is HKD 9.71
+0.09 (0.94%)
Apr 2, 2026, 4:08 PM HKT
CSPC Pharmaceutical Group Revenue
In the year 2025, CSPC Pharmaceutical Group had annual revenue of 26.01B CNY, down -10.35%. CSPC Pharmaceutical Group had revenue of 6.11B in the quarter ending December 31, 2025, a decrease of -3.29%.
Revenue
26.01B CNY
Revenue Growth
-10.35%
P/S Ratio
3.84
Revenue / Employee
1.32M CNY
Employees
19,700
Market Cap
111.01B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.01B | -3.00B | -10.35% |
| Dec 31, 2024 | 29.01B | -2.44B | -7.76% |
| Dec 31, 2023 | 31.45B | 513.21M | 1.66% |
| Dec 31, 2022 | 30.94B | 3.07B | 11.02% |
| Dec 31, 2021 | 27.87B | 2.92B | 11.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 81.73B |
| BeOne Medicines AG | 41.59B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 35.43B |
| WuXi Biologics | 24.25B |
| Hansoh Pharmaceutical Group Company | 16.72B |
| Innovent Biologics | 14.51B |
| WuXi XDC Cayman | 6.61B |
CSPC Pharmaceutical Group News
- 2 months ago - AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China's CSPC - WSJ
- 2 months ago - China's CSPC Pharmaceutical inks deal with AstraZeneca for weight loss therapy - Reuters